Академический Документы
Профессиональный Документы
Культура Документы
R2 Financial Technologies
Dan Rosen
R2 Financial Technologies
Outline
Introduction
Examples
Concluding remarks
Counterparty
exposures
and limits
Economic capital
Credit + market
risk (CVA)
Basel III...
CVA is now an integral
part of current accounting
rules for P&L, and of the
new proposal for banking
regulation (Basel III
rules)
12
Dan Rosen
R2 Financial Technologies
Prior to mid-2007, CVA was either ignored by dealers, or too small to be noticed
by customers
Ideally, it should be part of the trade valuation but calculated separately because
of portfolio effects
Banks existing portfolio of trades and the credit mitigation used in the deal
13
Some banks started to price and hedge CVA in the mid 1990s
More recently, more banks started to price and actively hedge CVA
Various large banks already manage CVA risks as part of their Trading
Books: daily MtM, active hedging, enforced market risk limits and intent to
transfer out the CVA risks
Others have opted for CVA desks deployed in their main business units
Subject to risk limits and usually do not have a revenue generation budget
14
2006-2011
R2 Financial Technologies
2009
14IACPM
Dan Rosen
R2 Financial Technologies
Some Definitions
Accounts for netting and collateral, but is generally not adjusted by possible
recoveries
Potential future exposure (PFE): current exposure plus the potential future
changes in exposures during the contracts lives
Accounts for the aging of the portfolio and underlying market factor movements
which directly affect contract values at a future times
If future rates rise, the contract can have a positive value potential
exposure to holder
17
Computing CVA
N
V (t ) = Vi (t )
i =1
E ( t ) = max {0,Vi (t )}
i =1
E (t ) = max {V (t ), 0}
Counterparty PFE
35
Mean Exposure
95 Percentile
30
Con d. EPE
25
Instantaneous collateral
C (t ) = max {V (t ) H ,0}
Exposure ( Million)
20
15
10
5475
5110
4745
4380
4015
3650
3285
2920
2555
2190
1825
1460
1095
730
365
Time (days)
18
Dan Rosen
R2 Financial Technologies
Exposures
Default
Migration
Recovery
19
Simulation
(Valuation)
2.
Pricing
Counterparties
Scenarios
Instruments
Assets
V (p, S, t)
Mark-to-Future
Values
3. CP aggregation,
mitigationgeneration
3. Exposure
(netting,collateral...)
collateral)
(netting,
PFE (P, S, t)
Tim
e
4. PFE
4. Exposures
Statistics
statistics
Maximum Peak
Exposure (T)
Effective
EPE (T)
EPE
(T)
Effective
Expected
Exposure
Expected
Exposure
20
Dan Rosen
R2 Financial Technologies
L = 1 T (1 R) E ( ) D( )
{ }
where
e(t ) = E t [ D (t ) E (t ) ] E D (t ) E (t ) = t
is the risk-neutral discounted expected exposure (EE) at t,
conditional on the CPs default at t
(everything is under the risk-neutral measure)
2006-2011 R2 Financial Technologies
21
The calculation of CVA and CVA contributions can be easily incorporated to the
Monte Carlo simulation of the counterparty-level exposure
In general, exposures are simulated separately implicitly assume that they are
independent of counterparties credit quality
22
Dan Rosen
R2 Financial Technologies
CVA = (1 R ) k e(t k )[ P (t k ) P (t k 1 )]
e(tk ) = M1
M
j =1
D ( j ) (t k ) E ( j ) (t k )
Counterparty PFE
35
Mean Exposure
95 Percentile
30
Co nd. EPE
25
Exposure ( Million)
20
15
10
5475
5110
4745
4380
4015
3650
3285
2920
2555
2190
1825
1460
1095
730
365
Time (days)
23
Vi (t ) = i (t ) + i (t ) X i
e(t ) = E t [ D (t ) E (t ) ] E D (t ) E (t ) = t
(t )
(t )
e (t ) = ( t )
+ (t )
(
t
)
(t )
(t )
(t ) H
e(t ) = (t )
(
t
)
(t )
(t )
(t ) H
(t ) H
+ (t )
+ H
(
t
)
(
t
)
(t )
2006-2011 R2 Financial Technologies
24
Dan Rosen
R2 Financial Technologies
Basel III introduces a new charge for MtM losses (CVA spread risk):
associated with a deterioration in the credit worthiness (greater source of
losses than outright defaults)
The total CCR charges aim to cover default, migration and spread risks
Portfolio capital charge based on Eff EPE using current market data
N
PD MF (M , PD )
Basel Capital = LGD j EAD j N
j
j
j
1 j
j =1
( )
EC LT
=
EC LEPE
Supervisory alpha = 1.4 allow for own estimate, subject to floor = 1.2
32
Dan Rosen
R2 Financial Technologies
Using the banks VaR model for bonds restricted to changes in credit
spreads, and does not model the sensitivity of CVA to other factors
CVA capital charge includes general and specific credit spread risk
From a market risk perspective, CVA is just essentially another price risk
Full simulation
Sensitivities
0.10
Normal
0.08
Probability
0.06
0.04
0.02
0.00
-140
Counterparty PFE
-100
-60
-20
21
61
101
141
35
Mean Exp osure
95 Percen tile
30
Co nd . EPE
25
Exposure ( Million)
20
15
10
e (t ) = E t [ D (t ) E (t ) ] E D (t ) E (t ) = t
5475
5110
4745
4380
4015
3650
3285
2920
2555
2190
1825
1460
1095
730
365
Time (days)
34
Dan Rosen
R2 Financial Technologies
Calibration
Spreads
For individual CPs where available, otherwise proxy by rating, industry,
region
For stressed VaR using the most severe one-year period in the
exposure stressed calibration
EE
Non-stressed VaR EE with current parameter calibration of exposures
Stressed VaR EE according to stressed exposure calibration
35
h = 1 (one-year horizon)
The level and reasonableness of the standardised CVA risk capital charge, including a
comparison to the advanced approach, is subject to a final impact assessment targeted
for completion in the first quarter of 2011.
2006-2011 R2 Financial Technologies
36
10
Dan Rosen
R2 Financial Technologies
Analytical expressions
Y = 1[ P ( )]
2
X i = bY
i + 1 bi X i
i (t ) E[ Vi (t ) | = t ] = i (t ) + i (t )bi 1[ P(t ) ]
i (t ) StDev[ Vi (t ) | = t ] = i (t ) 1 bi2
i (t ) =
i (t ) bi (t )
(1 bi2 )[1 2(t )]
39
11
Dan Rosen
R2 Financial Technologies
Stress testing
40
CP exposures
(Simulated from market factors)
Copula
Correlation parameters:
Capital
41
12
Dan Rosen
R2 Financial Technologies
Copula (X, Z)
Codependence of
exposures and credit events
Credit events
Exposures
(market
scenarios)
Yi = Z + 1 i
Ei = f ( X )
N 1 (PD ) z
PD(Z ) = N
Syst. factor
X
Syst. factor
Z
Idiosyncratic
CP factors
42
e (t k ) = j D j (t k ) E j (t k )
M
P ( j , t k 1 < < t k )
P (t k ) P(t k 1 )
Mean Exposure
95 Percentile
30
Cond. EPE
25
Exposure ( Million)
20
15
10
5475
5110
4745
4380
4015
3650
3285
2920
2555
2190
1825
1460
1095
730
365
Time (days)
45
13
Dan Rosen
R2 Financial Technologies
Linear Approximation:
CVA
(PDOld )
PD
46
One can show that (from the analytical formulas for the derivatives)
that fixing the expected exposure at default will be conservative
(aggressive) in the presence of wrong-way risk (right-way risk).
CVA
PD
2006-2011 R2 Financial Technologies
47
14
Dan Rosen
R2 Financial Technologies
T
0
e * (t)dPi (t)
e * (t k ) + e * (t k1 )
(P(t k ) P(t k1 ))
k=1
2
D j (t k ) E j (t k ) P( j | i = t k )
CVA (1 Ri )
e * (t k ) =
2006-2011 R2 Financial Technologies
48
PD(Z ) = N
Copula (X, Z)
Syst. factor
X
Syst. factor
Z
Idiosyncratic
CP factors
49
15
Dan Rosen
R2 Financial Technologies
Case Study
Sample portfolio: 70 counterparties
PFE profiles - simulated over 30 years using 2,000 market scenarios and 21
time steps (MtF)
800%
95% Percentile
700%
%5 Percentile
Mean exp
% Mean e xposure
600%
500%
3
400%
2
300%
200%
100%
Single Step
Multi-Steps 59 TS - MS / MS
Multi-Steps 59 TS - MS / SS
1.40
Alpha
1.20
Alpha
1.40
1.30
1.30
1.20
1.10
1.10
1.00
1.00
0.90
0.90
0.80
-1
0.80
-1
1.60
95t h Percentile
5th Percentile
158,032
154,454
127,155
98, 508
95, 401
199,954
238,365
152,864
116,262
110,398
120,191
83,296
102,277
79,307
80,209
-0.25
94, 691
84, 931
79, 592
78, 014
-0.25
59, 223
0 Correlation
0.25
Correlation
1.50
Multi-Steps 59 TS - MS / SS
No Count erparties:
Sigma1.40 No CP Exp Zero or Neg:
140,345
91,878
90,347
82,675
0.25
74,456
0.5
51,071
78,495
70,976
73,494
0.75
44,392
0.5
0.75
70
1.40
15.19%
1.30 1.30
30.75%
1.20 1.20
12.23%
11.26%1.10
1.10
9.58%
1.00
28.68%
1.00
4.72%0.90
7.41%
0.90
0.80
3.58%
0.80
15.45%
-1
(99.9%)
StressStatistics
Exposures ('000s) Multi-Steps 12 TS - MS
Mean
Exposure
Portfolio
Size Statisti cs
Single
Step
/ MS
Multi-Steps
59 TS - MS / MS2,176,463
Multi-Steps
12 TS - MS
Total Exposure:
Exposure
> / SS No of CP No of Eff CP
1.50
A48010615
6EAD4TE
284500046
9CRUPAR
90000001
Y18500690
10048092
280580040
6KHBNYC
-0.75
-0.5
P40010019
5.651.60
Multi-Steps 12 TS - MS / MS
Multi-Steps 12 TS - MS / SS
Counterparty
-0.75 Confidential
-0.5
Client
Base
Case
Alpha
- Systematic
Skew*:
Maximum :
Largest(10):
Smallest(10):
-0.75
-0.5
Minimum:
-1
-0.75
-0.5
-0.25
HI
70
32
0.031
100,000
69
31
0.032
1M
69
31
0.032
No of Eff CP
Average Stress
% Vol:Exposures 17.71%
1.50
Exposure ('000s)
1.70
A lpha
1.50
1.80
- Total (99.9%)
Alpha
Base CaseAlpha
1.60
0%
1.70
Frequency
30
20
2.21
10
158,032
0
59,223
8,505.34
CPs
-0.25
0
0.25
0.5 No of0.75
1
8,053.13
Correlation
0
0.25
0.5 Copyright
0.75
R2 Financial1Tec hnologies 2007
Correlation
-0.5
0.92
Stressed Exposures
Multi-Steps 12 TS - MS / MS
Alpha Systematic (LSS/LSD)
MS / SS
Base Case
Multi-Steps 59 TS - MS / MS
Stressed
MS / Exposures
SS
Alpha Systematic (LSS/LSD)
Single Step
Multi-Steps 12 TS - MS / MS
MS / SS
Multi-Steps 59 TS - MS / MS
MS / SS
0.91
0.91
0.94
0.97
0.96
0.99
1.00
1.06
1.05
-0.5
0.89
0.89
0.92
0.95
0.94
0.97
0.97
0.93
1.00
-0.25
-0.25
0.92
0.95
0.97
0.96
0.99
0.97
0.97
0.97
0.93
0.96
0.99
0.25
0.25
1.04
1.04
1.06
0.99
1.02
0.96
1.00
1.03 0.97
1.07
1.10
1.01
1.06
1.09 1.02
0.96
0.94
1.00
0.96
1.01
1.01
1.00
1.06
1.01
1.06
0.5
0.5
1.12
1.12
1.13
1.15
1.18
1.08
1.13
1.16 1.11
1.26
1.22
1.25
1.18
1.21
1.24 1.25
Client Confidential
1.06
1.03
1.10
1.04
1.09
0.93
0.94
0.99
0.93
0.97
0.93
0.93
0.98
0.94
0.98
1.08
1.08
1.14
1.08
1.13
0.75
0.75
1.21
1.21
1.30
1.30
1.41
1.29
1.33
1.30
1.29
1.33 1.44
1.42
1.42
1.63
1.39
1.43
1.42
1.38
1.42 1.74
1.18
1.16
1.23
1.16
1.21
Client Confidential
1.30
1.24
1.32
1.26
1.31
1.42
1.37
1.45
1.34
1.40
51
Portfolio Exposures
Portfolio Exposure Summary: Regulatory Capital
One-Year Equivalent Exposures
300%
95% Percentile
5
%5 Percentile
% Mean exposure
Mean exp
200%
3
150%
2
100%
Frequency
250%
50%
0%
Exposure ('000s)
17.71%
5.65
Mean
95th Percentile
5th Percentile
Sigma
P40010019
158,032
154,454
127,155
98,508
95,401
94,691
84,931
79,592
78,014
59,223
199,954
238,365
152,864
116,262
110,398
140,345
91,878
90,347
82,675
74,456
120,191
83,296
102,277
79,307
80,209
51,071
78,495
70,976
73,494
44,392
15.19%
30.75%
12.23%
11.26%
9.58%
28.68%
4.72%
7.41%
3.58%
15.45%
1
A48010615
2
6EAD4TE
3
284500046
4
9CRUPAR
5
90000001
6
Y18500690
7
10048092
8
280580040
9
6KHBNYC
10
70
1 Euro
31,092
15,947.26
33,411
4.53
2.21
158,032
59,223
8,505.34
8,053.13
No of CP No of Eff CP
HI
70
32
0.031
100,000
69
31
0.032
Average % Vol:
30
20
10
0
No of CPs
Copyright R2 Financial Technologies 2010
52
16
Dan Rosen
R2 Financial Technologies
400
Mean Exposure
350
3.20
Hazard Rate
HR Volatility
3.10
Asset
Correlation
300
95 Percentile
CVA ( Million)
Exposure ( Million)
250
200
150
100
50
0
Mean Exposure
Cond Mean Exposure
95 Percentile
80
3.00
40
20
0.25
-0.50
1.36
0.25
0.50
0.75
5475
5110
4745
4380
4015
3650
3285
2920
0.50
3.20
2555
2190
1825
0
Correlation
1460
1.31
-0.25
1095
-0.75
2.87
60
730
-1
2.80
42.88
35.50
59.35
2.81
3.44
Statistics ( million)
Exposure
2.90
Actual Exposure
EPE
2.80
Effective EPE
Effective Maturity*
2.70
Total Capital
CVA
Mkt-2.60
Credit Corr.
-1
-0.75
CVA Unilateral
CVA Bilateral
CVA Uncorrelated
Correlation
CVA
0.024
0.0500
0.2149
Exposure
Testing
365
5475
Time in Days
5110
4745
4380
4015
3650
3285
2920
2555
2190
1825
1460
1095
730
365
Statistics ( million)
Exposure
Actual Exposure
304.64
EPE
158.03
Effective EPE
305.84
Effective Maturity*
1.57
Total Capital
8.51
CVA
Market-Credit Corr.
0.25
CVA Unilateral
3.13
CVA Bilateral
CVA Uncorrelated
3.06
Counterparty Info
CVA Stress
Counterparty
6MPEBTQ
No of3.40
Instruments
11
120
Sector
INDUSTRIALS
BBB3.30 Rating
PD
0.3059%
100
LGD
0.40
Exposure
( Million)
Counterparty Info
Counterparty
A48010615
No of Instruments
111
Sector FINANCIALS
Rating
BBB+
PD
0.1367%
LGD
0.40
Hazard Rate
0.024
HR Volatility
0.0500
Asset Correlation
0.2149
Time in Days 1
0.75
3.26
3.33
53
130
1800
120
Deterministic
Deterministic - Syst
110
Stochastic
Stochastic - Sys
1600
1400
Frequency (Thousands)
100
90
VaR
80
70
60
50
40
1200
1000
800
600
30
400
20
200
10
0
VaR 90%
VaR 95%
VaR 99%
Quantile
4.42
4.42
100%
4.42
4.42
100%
Capital
111.81
58.59
52%
118.33
59.18
50%
Sigma
VaR 90%
VaR 95%
VaR 99%
VaR 99.5%
VaR 99.9%
ES 99.9%
11.68
6.26
54%
12.04
6.30
52%
14.91
10.07
68%
14.59
10.11
69%
23.99
14.87
62%
24.21
14.93
62%
59.85
30.27
51%
57.90
30.42
53%
71.54
38.72
54%
76.62
38.83
51%
116.23
63.01
54%
122.74
63.60
52%
150.70
82.42
55%
157.30
82.95
53%
Client Confidential
54
17
Dan Rosen
R2 Financial Technologies
1.40
VaR Based
1.20
Capital Based
1.00
1.40
VaR Based
1.20
Capital Based
Alpha
Alpha
1.00
0.80
0.80
0.60
0.60
0.40
0.40
0.20
0.20
0.00
0.00
-1
-0.75
-0.5
-0.25
0
Correlation
0.25
0.5
0.75
-1
-0.75
-0.5
-0.25
0
Correlation
0.25
0.5
0.75
Alpha Multiplier by Correlation level at 99.9% (Between Exposures and Credit Events)
Correlation
-1
-0.75
-0.5
-0.25
0.25
0.5
0.75
VaR Based
0.89
0.92
0.97
1.01
1.06
1.11
1.16
1.22
1.28
Capital Based
0.89
0.92
0.97
1.01
1.06
1.12
1.16
1.22
1.29
0.81
0.81
0.85
0.84
0.90
0.89
0.95
0.95
1.01
1.01
1.07
1.07
1.14
1.15
1.22
1.23
1.32
1.34
55
900
880
Exposure (millions)
860
840
820
800
780
760
740
720
700
151
301
451
601
751
901
Scenario Statistics
No Scenarios:
Maximum*:
Mean*:
Median*:
STD*:
Minimum*:
* million
2,000
1,144.17
885.37
880.52
53.41
752.61
Principal Components
PC
Explained Variation
First
69.60%
Second
14.95%
Third
5.75%
57
18
Dan Rosen
R2 Financial Technologies
58
1.70
1.60
Base Case
1.70
Base Case
1.50
Stress Exposures
1.60
Stress Exposures
1.50
Alpha
1.40
Alpha
1.80
1.30
1.20
1.40
1.30
1.20
1.10
1.10
1.00
1.00
0.90
0.90
0.80
0.80
-1
-0.75
-0.5
-0.25
0
Correlation
0.25
0.5
0.75
-1
-0.75
-0.5
-0.25
0
Correlation
0.25
0.5
0.75
-0.5
-0.25
0.25
0.5
0.75
0.92
0.97
1.04
1.12
1.21
1.30
1.42
1.00
0.97
0.97
0.99
1.06
1.13
1.26
1.41
1.63
1.06
1.05
0.93
1.00
0.93
0.96
0.96
0.97
1.01
1.02
1.08
1.11
1.18
1.25
1.30
1.44
1.42
1.74
Client Confidential
59
19
Dan Rosen
R2 Financial Technologies
4.5
4
3.5
3
2.5
2
1.5
1
0.5
0
1981
1986
1991
1996
2001
2006
4.000
4.00
Equity Index
3.000
Equity Index
1.000
1.00
0.000
0.00
1981 1983 1985 1987 1989 1991 1993 1995 1997 1999 2001 2003 2005 2007
1981
-1.000
-1.00
-2.000
-2.00
3.00
1986
1991
1996
2001
2006
66
For simplicity, use same exposures as for CCR capital (not risk-neutral)
Credit model
Constant risk-neutral HR per rating (real PDs also per rating and higher
than we have used in the past at BBVA)
Portfolio Exposure Sum mary: Regulatory Capital
6
95% Percentile
700%
%5 Percentile
Mean exp
600%
% Mean exposure
800%
500%
3
400%
Alpha - Systematic
Alpha
(99.9%): Comparison
Single(99.9%)
vs Multiple Steps
1.80
200%
1.70
0%Stress Exposures
1.50
1.50
1.40
1.40Multi-Steps 59 TS - MS / MS
Single Step
1.50
Multi-Steps 59 TS - MS / MS
17.71%
1.20
1.30
1.00
0.90
0.80
0.90
-1
0.80
-1
-0.75
Counterparty
Mean
95t h Percentile
5th Percentile
A48010615
6EAD4TE
284500046
9CRUPAR
158,032
154,454
127,155
98, 508
199,954
238,365
152,864
116,262
120,191
83,296
102,277
79,307
90000001
-0.75
-0.5
Y18500690
10048092
-0.5
-0.25
280580040
95, 401
-0.25
0
94, 691
Correlation
84, 931
0 592
0.25
79,
110,398
0.25
140,345
0.5
91,878
0.5
90,347
0.75
P40010019
59, 223
Alpha (99.9%)
as aTotal
function
of market-credit correlation
Alpha
(LTS/LTD)
Client
Confidential
Correlation
-1
-0.75
Base Case
Multi-Steps 12 TS - MS / MS
0.94
MS / SS Base Case0.97
Stressed
Multi-Steps 59 TS - MS
/ MS Exposures0.96
MS / SS
0.99
Alpha Systematic (LSS/LSD)
Single Step
Multi-Steps 12 TS - MS / MS
MS / SS
Multi-Steps 59 TS - MS / MS
MS / SS
1.06
1.03
1.10
1.04
1.09
-0.5
80,209
0.75
51,071
78,495
1
70,976
73,494
-0.5
44,392
-0.25
0.92
-0.2515.45%
0.97
0.89
0.97
0.95
0.930.97
1.00 0.96
0.99
0.99
0.931.02
0.96 1.00
1.03
1.07
0.961.10
0.97 1.06
1.09
0.93
0.94
0.99
0.93
0.97
0.93
0.93
0.98
0.94
0.98
0.96
0.94
1.00
0.96
1.01
1.01
1.00
1.06
1.01
1.06
0.97
0.99
1.04
1.04
1.06
0.25
0.5
Minimum:
0.25
1.12
1.12
1.13
8,053.13
0.5
1.21
1.15
1.22
1.01 1.18
1.08 1.25
1.02 1.13
1.11 1.21
Client Confidential
1.16
1.24
1.08
1.08
1.14
1.08
1.13
Client Confidential
70
32
HI
0.031
0.032
0.032
1.00
0.92
1.060.95
1.050.94
0.97
0.97
No of CP No of Eff CP
0.91
0.92
Exposure >
1.20
1.00
0.89
No of Eff CP
1.10
1.40
Multi-Steps 12 TS - MS / MS
Exposure ('000s)
Multi-Steps 12 TS - MS / SS
1.40 Multi-Steps 59 TS - MS / SS
5.65
Mean Exposure Statistics ('000s)
1.30
Total Exposure:
2,176,463
1.20
No Count erparties:
70
A lpha
Average % Vol:
1.20
1.00
1.30
Alph a
Alpha
Alp ha
1.30
Base Case
Alpha
- Systematic (99.9%)
Stress Exposures
1.60
1.60
Multi-Steps 12 TS - MS / MS
Counterparty
Multi-Steps
12 TS (Top
- MS 70
/ SSmean ex posures)
Multi-Steps 59 TS - MS / SS
1.70
100%Base Case
1.60
300%
Freque ncy
1.18
1.16
1.23
1.16
1.21
1.21
1.26
0.75
1.30
No
1 of CPs
0.75
1.30
1.41
1.42
1.42
1.63
1.29
1.39
1.18 1.33
1.30 1.43
1.42
1.25 1.29
1.44 1.38
1.74
Copyright R2 Financial Technologies 2008
1.33
1.42
1.30
1.24
1.32
1.26
1.31
1.42
1.37
1.45
1.34
1.40
72
20
Dan Rosen
R2 Financial Technologies
Portfolio CVA
Portfolio CVA Summary
Portfolio Summary ( million)
No of CPs
70
Mkt-Credit Corr.
0.25
Mean
Median
STD
Kurtosis*
Skew*
Maximum
Largest 10
Smallest 10
Minimum
1.08
0.39
2.57
41.22
5.95
19.76
1.46
0.10
0.004
2,291
3,882
2,176
75.80
55.53
13.44
CVA by Counterparty
25
20
( Million)
Mark-to-Market
Actual Exposure
EPE
CVA
Unilateral
Bilateral
Capital
CCR Capital
CVA VaR
15
10
5
0
Counterparties
CVA
CVA Concentration
76.00
( Million)
75.00
74.00
Central
Bank, 0.34
Internationa
l Corporates,
41.18
73.00
Large
Domestic
Corporates,
8.48
Other
Corporates,
6.00
72.00
71.00
70.00
-1
-0.75
-0.50
-0.25
0
Correlation
-0.25
74.68
0.25
0
75.23
0.50
0.25
75.80
0.75
0.50
76.38
Financials,
39.69
0.75
76.96
Project
Finance,
22.86
1
77.54
73
1.60
Mean Exposure
100
1.50
1.40
(CVA Million)
80
( Million)
42.88
35.50
59.35
2.81
3.44
120
60
1.30
1.20
40
1.10
20
1.00
0.25
1.36
-1
-0.75
-0.50
Time in Days
-0.25
0.25
0.50
0.75
Correlation
5475
5110
4745
4380
4015
3650
3285
2920
2555
2190
1825
1460
1095
730
1.31
365
Statistics ( million)
Exposure
Actual Exposure
EPE
Effective EPE
Effective Maturity*
Total Capital
CVA
Mkt- Credit Corr.
CVA Unilateral
CVA Bilateral
CVA Uncorrelated
Exposure
Correlation
CVA
-1
1.08
-0.75
1.14
0.50
1.41
0.75
1.45
1
1.48
74
21
Dan Rosen
R2 Financial Technologies
77
3.00E+06
Linear Approximation
2.00E+06
1.00E+06
0.00E+00
VaR 0.90 VaR0.95 VaR 0.99 VaR 0.995 VaR 0.999
CVaR
0.999
79
22
Dan Rosen
R2 Financial Technologies
Linear Approximation
5.10E+06
5.00E+06
4.90E+06
4.80E+06
4.70E+06
4.60E+06
4.50E+06
4.40E+06
4.30E+06
-0.75
-0.5
-0.25
0.25
0.5
0.75
80
Capital Charges
-1
-0.75
-0.5
-0.25
0.25
Base Case
87.48
88.11
88.76
89.43
90.13
90.85
Stress Case
109.35
110.14
110.95
111.78
112.66
113.56
0.5
0.75
91.58
92.32
93.08
114.47
115.41
116.35
81
23
Dan Rosen
R2 Financial Technologies
Concluding Remarks
83
CVA must be priced for derivatives portfolios the crisis showed its
practical role and impact
We are just starting to understand its modelling and its financial, regulatory
and management requirementsand impacts
Basel III regulation is not yet fully aligned with some of the best
practices, but will likely move there over time
84
24
Dan Rosen
R2 Financial Technologies
Complex risks
10s or 100s of market factors driving exposures over very long horizons
Wrong-way risk
85
Final Lessons
Model risk frameworkC
Develop explicit model risk and stress testing approaches which can
help us understand better
90
25
Dan Rosen
R2 Financial Technologies
93
Rosen D. and Saunders D. 2011, Structured Finance Valuation and Risk Management with
Implied factor Models, in Advances in Credit Derivatives, Bloomberg Publications
Nedeljkovic, J., Rosen D. and Saunders D. 2010, Pricing and Hedging CLOs with Implied
Factor Models, Journal of Credit Risk, fall issue
Rosen D. and Saunders D. 2009, Valuing CDOs of Bespoke Portfolios with Implied MultiFactor Models, Journal of Credit Risk, Fall Issue
Rosen D. and Saunders D. 2011, Wrong-Way CVA and CVA VaR, working paper
Pykhtin M., Rosen D. 2010, Pricing Counterparty Risk at the Trade Level and CVA
Allocations, Federal Reserve Research Paper Series (Journal of Credit Risk)
Rosen D. and Saunders D. 2010, Computing and Stress Testing Counterparty Credit Risk
Capital, in Counterparty Credit Risk Modelling, (ed. E. Canabarro), Risk Books
Garcia Cespedes J. C., de Juan Herrero J. A., Rosen D., Saunders D. 2010, Effective
modelling of Counterparty Credit risk Capital and Alpha, Journal of Risk Model validation
De Prisco B., Rosen D., 2005, Modelling Stochastic Counterparty Credit Exposures for
Derivatives Portfolios, Counterparty Credit Risk (M. Pykhtin, Editor), Risk Books
94
26
Dan Rosen
R2 Financial Technologies
Rosen D. and Saunders D. 2010, Risk Contributions and Economic Credit Capital Allocation,
in Advances in Credit Derivatives, Bloomberg Publications (forthcoming)
Rosen D. and Saunders D. 2009, Analytical Methods for Hedging Systematic Credit Risk
with Linear Factor Portfolios, Journal of Economic Dynamics and Control
Mausser H. and Rosen D. 2007, Economic Credit Capital Allocation and Risk Contributions,
in Handbook of Financial Engineering (J. Birge and V. Linetsky Editors)
Garcia Cespedes J. C., Keinin A., de Juan Herrero J. A. and Rosen D. 2006, A Simple
Multi-Factor Factor Adjustment for Credit Capital Diversification, Special issue on Risk
Concentrations in Credit Portofolios (M. gordy, editor) Journal of Credit Risk, Fall 2006
Rosen D., 2004, Credit Risk Capital Calculation, in Professional Risk Manager (PRM)
Handbook, Chapter III.B5, PRMIA Publications
Aziz A., Rosen D., 2004, Capital Allocation and RAPM, in Professional Risk Manager (PRM)
Handbook, Chapter III.0, PRMIA Publications
95
www.R2-financial.com
27